
AML: Genetic Testing Unlocks Hope
Acute myeloid leukemia (AML) remains a deadly blood cancer, but survival rates are improving, especially in children. Advances in treatment options, including targeted therapies and venetoclax, have led to better outcomes for adult patients. The goal of treatment is to achieve complete remission. Despite progress, there are challenges in treating high-risk cases, such as patients…